Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
James Nisco is SVP, Fin/Treas, Chief Actg Off at Lisata Therapeutics. OQRO lists 6 transactions filed with the SEC under this name, the latest on Jan 13, 2026, each linked to the official Form 4.
SVP, Fin/Treas, Chief Actg Off
Disclosures on record
6
Companies involved
1
Lisata TherapeuticsLSTA
6 disclosures · Jan 2026
Jan 9, 202615Kdisclosed Jan 13
DetailsOfficial recordJan 9, 20267,000disclosed Jan 13
DetailsOfficial recordJan 9, 20262,131disclosed Jan 13
DetailsOfficial recordJan 9, 20262,131disclosed Jan 13
DetailsOfficial recordJan 9, 20261,137disclosed Jan 13
DetailsOfficial recordJan 9, 2026781disclosed Jan 13
DetailsOfficial recordAs of the latest filing on , James Nisco reported holding 32,311 shares of Lisata Therapeutics (LSTA), worth about $39K at the last close of $1 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Lisata Therapeutics LSTA | 32,311 | 32K direct | $1 | $39K | Jan 9, 2026 |
Is this James Nisco’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Jan 9, 2026, James Nisco reported holding 32,311 shares of Lisata Therapeutics (LSTA). At the last close of $1 on Nov 13, 2026, that is about $39K. This is the stake disclosed in filings, not a net worth.